Department of Surgery, The Chinese University of Hong Kong, Hong Kong; Department of Surgery, Prince of Wales Hospital, New Territories, Hong Kong.
Department of Surgery, Prince of Wales Hospital, New Territories, Hong Kong.
Surgeon. 2021 Dec;19(6):329-337. doi: 10.1016/j.surge.2020.11.013. Epub 2021 Jan 8.
Although hepatectomy is a curative treatment modality for hepatocellular carcinoma (HCC), the associated 10-year long-term actual survival are rarely reported. This study aims to develop and validate a predictive nomogram for 10-year actual survivors with HCC.
From 2004 to 2009, 753 patients with curative hepatectomy for HCC (development set, n = 325; validation set, n = 428) were included. In development set, comparison of clinic-pathological data was made between patients surviving ≥10 years and those surviving <10 years. Good independent prognostic factors identified by multivariate analysis were involved in a nomogram development, which was validated internally and externally using validation set.
On multivariate analysis, five independent good prognostic factors for 10-year survival were identified, including young age (OR = 0.943), good ASA status (≤2) (OR = 2.794), higher albumin level (OR = 1.116), solitary tumor (OR = 2.531) and absence of microvascular invasion (OR = 3.367). A novel nomogram was constructed with C-index of 0.801 (95% CI 0.762-0.864). A cut-off point of 167.5 had a sensitivity of 0.794 and specificity of 0.730. Internal validation using bootstrap sampling and external validation using validation set revealed C-index of 0.792 (95% CI, 0.741-0.853) and 0.761 (95% CI, 0.718-0.817).
A novel nomogram for 10-year HCC survivor using age, ASA status, preoperative albumin, tumor number and presence of microvascular tumor invasion was developed and validated with high accuracy.
虽然肝切除术是治疗肝细胞癌(HCC)的一种根治性治疗方法,但很少有报道其 10 年的实际长期生存率。本研究旨在建立和验证一种预测 HCC 患者 10 年实际生存者的预测列线图。
从 2004 年到 2009 年,共纳入 753 例接受根治性肝切除术治疗 HCC 的患者(发展集,n=325;验证集,n=428)。在发展集中,比较了生存时间≥10 年和<10 年的患者的临床病理数据。通过多因素分析确定了良好的独立预后因素,并将其纳入列线图的建立,然后使用验证集进行内部和外部验证。
多因素分析确定了 5 个与 10 年生存相关的独立良好预后因素,包括年龄较小(OR=0.943)、良好的美国麻醉医师协会(ASA)状态(≤2)(OR=2.794)、较高的白蛋白水平(OR=1.116)、单发肿瘤(OR=2.531)和无微血管侵犯(OR=3.367)。建立了一个新的列线图,C 指数为 0.801(95%CI,0.762-0.864)。截断值为 167.5 时,灵敏度为 0.794,特异性为 0.730。使用 bootstrap 抽样进行内部验证和使用验证集进行外部验证,C 指数分别为 0.792(95%CI,0.741-0.853)和 0.761(95%CI,0.718-0.817)。
使用年龄、ASA 状态、术前白蛋白、肿瘤数量和微血管肿瘤侵犯的存在,建立并验证了一种预测 HCC 患者 10 年生存者的新型列线图,具有较高的准确性。